Long-Term Effects Secondary to Cancer Therapy in Adults Completed Phase 1 / 2 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0038922 (Long-Term Effects Secondary to Cancer Therapy in Adults)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00389584Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid TumorsTreatment